189 Epizód

  1. Rationale for NTRK Testing in Patients With Cancer

    Közzétéve: 2021. 10. 08.

  2. Expert Answers to HCP Questions on Androgen Deprivation Therapy for Prostate Cancer

    Közzétéve: 2021. 10. 07.

  3. Expert Insight on Important Clinical Trial Data From ESMO 2021 Informing Treatment for Endometrial and Ovarian Cancer

    Közzétéve: 2021. 09. 29.

  4. Expert Insight on New Evidence Poised to Change the Treatment Landscape in Melanoma

    Közzétéve: 2021. 09. 28.

  5. Expert Insight on Practice Changing From IGCS 2021 Informing Treatment for Endometrial, Ovarian, and Cervical Cancer

    Közzétéve: 2021. 09. 21.

  6. Integrating New Therapies Into the Management of Relapsed/Refractory Myeloma: Experts Address FAQs

    Közzétéve: 2021. 08. 24.

  7. Expert Insights on Optimal Use of CDK4/6 Inhibitors for HR-Positive/HER2-Negative Breast Cancer

    Közzétéve: 2021. 08. 19.

  8. Essential Biomarker Testing in GI Cancers

    Közzétéve: 2021. 08. 18.

  9. CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Expert Answers to Clinician Questions

    Közzétéve: 2021. 08. 05.

  10. The Latest Advances and Guidance in Nonmetastatic Castration-Resistant Prostate Cancer

    Közzétéve: 2021. 07. 30.

  11. Managing Serious Adverse Events Associated with BTK Inhibitor Treatment

    Közzétéve: 2021. 07. 27.

  12. Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 2: Patient Strategies for Self-Management

    Közzétéve: 2021. 07. 27.

  13. Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions

    Közzétéve: 2021. 07. 27.

  14. BTK Inhibitors in CLL and Lymphomas: Overview and Current Indications

    Közzétéve: 2021. 07. 23.

  15. Adverse Events Associated with BTK Inhibitor Treatment

    Közzétéve: 2021. 07. 23.

  16. Radiopharmaceuticals in the Treatment of Metastatic Castration-Resistant Prostate Cancer

    Közzétéve: 2021. 07. 20.

  17. How to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on BCMA-Targeted Therapies

    Közzétéve: 2021. 07. 19.

  18. Expert Answers to HCP Questions on CAR T-Cell Therapy

    Közzétéve: 2021. 07. 19.

  19. How to Integrate Novel Treatment Classes for R/R Myeloma Into Clinical Practice: Information on Selinexor, Venetoclax, and Melphalan Flufenamide

    Közzétéve: 2021. 07. 16.

  20. Caring for Patients With Newly Diagnosed Multiple Myeloma

    Közzétéve: 2021. 07. 14.

6 / 10

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Visit the podcast's native language site